HBM Healthcare Investments AG

HBM Healthcare Investments AG is a Swiss-based investment company specializing in the global healthcare sector. Its primary purpose is to provide shareholders with access to a diversified portfolio of high-growth private and public companies focused on biotechnology, medical technology, diagnostics, and digital health. With permanent capital and a dedicated investment strategy, the company manages assets of approximately $2.5 billion, deploying capital into both early-stage and established healthcare businesses worldwide. The portfolio spans companies that are at varying stages of development, from pre-clinical to market, and covers a broad geographic scope with significant investments in North America, Europe, and Asia. HBM Healthcare Investments AG plays a crucial role in fostering innovation within the life sciences, supporting firms that have achieved key clinical or regulatory milestones. The company emphasizes risk management through diversification, partial hedging, and a balance between private and public equities. Its track record includes numerous successful trade sales and IPOs, underscoring its market significance as an important bridge between innovative healthcare enterprises and global capital markets.